Inventor

CAMPOS SEBASTIEN ANDRE

GB7 patents

⚠️ This page may combine multiple inventors who share the name “CAMPOS SEBASTIEN ANDRE”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

GLAXOSMITHKLINE IP DEV LTD

4 patents

US9993514B2Jun 12, 2018

UNIV YALE

1 patent

US10730862B2Aug 4, 2020

Compounds and methods for the enhanced degradation of targeted proteins and other polypeptides by an E3 ubiquitin ligase

UNIV YALE15 citations80

CAMPOS SEBASTIEN ANDRE

1 patent

US8575181B2Nov 5, 2013

Purine derivatives for use in the treatment of allergic, inflammatory and infectious diseases

CAMPOS SEBASTIEN ANDRE13 citations78

GLAXOSMITHKLINE LLC

1 patent

US7687532B2Mar 30, 2010

Fused heteroaryl derivatives for use as p38 kinase inhibitors in the treatment of I.A. rheumatoid arthritis

GLAXOSMITHKLINE LLC5 citations61

CAMPOS SEBASTIEN ANDRE

GLAXOSMITHKLINE IP DEV LTD

Compounds

Benzothiophene derivatives as estrogen receptor inhibitors

Chemical compounds

Chemical compounds

UNIV YALE

Compounds and methods for the enhanced degradation of targeted proteins and other polypeptides by an E3 ubiquitin ligase

CAMPOS SEBASTIEN ANDRE

Purine derivatives for use in the treatment of allergic, inflammatory and infectious diseases

GLAXOSMITHKLINE LLC

Fused heteroaryl derivatives for use as p38 kinase inhibitors in the treatment of I.A. rheumatoid arthritis